Fundraising FoxAlbireo Pharma
2 known investors
Find your way into Albireo Pharma
Sign up to see every warm intro you have to Albireo Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Albireo Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A biopharmaceutical company (Ipsen, following its acquisition of Albireo Pharma) developing and commercializing medicines in oncology, rare diseases, and neuroscience for patients with high unmet medical needs. Its portfolio includes treatments for cancers, rare bone, liver, and neurogenetic disorders, and neurological conditions such as spasticity.
Investors · 2
Frequently asked questions
- What does Albireo Pharma do?
- A biopharmaceutical company (Ipsen, following its acquisition of Albireo Pharma) developing and commercializing medicines in oncology, rare diseases, and neuroscience for patients with high unmet medical needs. Its portfolio includes treatments for cancers, rare bone, liver, and neurogenetic disorders, and neurological conditions such as spasticity.
- Who are Albireo Pharma's investors?
- Albireo Pharma's investors include Decheng Capital, HEALTHCARE ROYALTY PARTNERS.